Apellis Pharmaceuticals Aktie
34,95
EUR
-0,03
EUR
-0,09
%
34,95
EUR
+0,07
EUR
+0,20
%
Werbung
Apellis Pharmaceuticals Aktie Analyse
| 01.08.19 | Apellis Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 30.07.18 | Apellis Pharmaceuticals Buy | B. Riley FBR | |
| 24.05.18 | Apellis Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 08.02.18 | Apellis Pharmaceuticals Buy | B. Riley FBR, Inc. |
Werbung
Werbung